Stakeholder analysis in health innovation planning processes: A systematic scoping review

Franco-Trigo, Lucía; Fernández-Llimós, Fernando; Martínez-Mart́inez, Fernando; Benrimoj, Shalom I.; Sabater‐Hernández, Daniel

doi:10.1016/j.healthpol.2020.06.012

Cited by 40 publications

(29 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies on the importance of stakeholder analyses have grown in recent decades, from its use in business evaluations to its more recent use in social policies, programs, projects and management in the health area [41], in line with the literature that identi es it as a basic step in the analysis process, demonstrating its importance [42]. Using a scoping review, L. Franco-Trigo et al [43] show that integrated changes in healthcare systems are complex efforts that will require a planned engagement design based on the guidelines indicated in the theoretical construct (stakeholder analyses), as addressed in Reed et al [44].…”

Section: Discussionmentioning

confidence: 97%

Primary Healthcare meta-evaluation in Brazil: Lessons learned from the external assessment of the program to improve primary healthcare access and quality.

Barca

Rocha

Martiniano

et al. 2022

Preprint

View full text Add to dashboard Cite

Introduction: The Primary Healthcare Access and Quality Improvement Program (PMAQ-AB) implemented in 3 evaluation cycles (2011-2019) represents a turning point in the performance assessment of Primary Healthcare (PHC) in Brazil.Methods: A cumulative meta-evaluation of the PMAQ-AB External Assessment (Avaliação Externa do PMAQ-AB - AE/PMAQ-AB) using the qualitative Case Study method. The matrix of indicators was prepared based on the 4 principles of the Joint Committee on Standards for Educational Evaluations (utility, feasibility, propriety and accuracy) articulated to each of the 6 stages of the evaluation proposed by the Centers for Disease Control and Prevention. Triangulation of collection methods (document analysis, interview and focus group) and participants (managers, professionals and evaluators) and Bardin’s content analysis were implemented.Results: The “Involvement of Stakeholders” presented agreement in the instances of the Unified Health System, expanding adhesion of the municipalities in the cycles, credibility of the evaluator and conciliation by the federal government in the interests of certification of the municipalities and of research by the universities as strengths; while the absence of users in the decision-making processes of formulating and executing the program as a weakness. The “Program Description” was positive in the consistency of the AE/PMAQ-AB with the National Primary Care Policy/2011. The “Assessment Design” portrayed the Brazilian PHC and construction of comparable standards and certification criteria. The use of information technology, logistics and guidelines for training the interviewers gave the collection homogeneity, pointing to the usefulness and feasibility. The “Systematization and Analysis of Evidence” had the online validation systems, offer of micro data, availability of electronic reports to stakeholders as strengths, but there were weaknesses in the methodology transmission to municipal managers, incipient strategies of technical empowerment for interpreting and applying the results, in turn negatively impacting the “Justification of Conclusions” dimension. The utility of AE/PMAQ-AB prevailed in “Sharing Lessons Learned” for an assessment culture in management, services, and academia. Conclusion: The meta-evaluation presents a systemic view of the AE/PMAQ-AB, helping managers and professionals in the PHC assessment process. It raises awareness of user engagement in policy and program assessments, making them more plural, participatory and democratic.

show abstract

Section: Discussionmentioning

confidence: 97%

Primary Healthcare meta-evaluation in Brazil: Lessons learned from the external assessment of the program to improve primary healthcare access and quality.

Barca

Rocha

Martiniano

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…This study aimed to analyse the stakeholders involved in the allocation of foreign currency subsidies, a policy implemented by the Iranian Government targeting access to medicines. Stakeholder analysis helps in identifying the main stakeholders and evaluating their knowledge, interests, and interventional power [ 47 , 58 ].…”

Section: Discussionmentioning

confidence: 99%

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis

Olyaaeemanesh

Jaafaripooyan

Abdollahiasl

et al. 2021

Health Res Policy Sys

View full text Add to dashboard Cite

Background Over the past three decades, allocation of foreign currency subsidies has been the primary strategy of various administrations in Iran to improve access to medicines. This strategy has resulted in several challenges, including stakeholder conflicts of interest. Objective To identify the power, interest, and role of the stakeholders in allocating foreign currency subsidies to medicines in the Iranian health system. Methods In this qualitative study, 39 semi-structured interviews were conducted. Key informants were recruited using a purposive sampling technique. The theoretical framework adopted by Varvasovszky and Brugha was employed. The data were analysed using directed content analysis. Results The foreign currency subsidy for medicines included 21 stakeholders in five main categories: governmental organizations, Iranian Parliament, general population, nongovernmental organizations (NGOs), and the pharmaceutical industry. Stakeholders varied in their level of participation and support in the policy-making process. Among them, the Iranian Government, Planning and Budget Organization, the Ministry of Health and Medical Education (MoHME), and Iran Food and Drug Administration (IFDA) were the most important stakeholders, with highly supportive positions, while domestic drug manufacturers were the strongest opponents of this policy. The Government of Iran is the most powerful institution with regard to the ability to allocate foreign currency subsidies to medicines, followed by the MoHME and the IFDA. Conclusion This study demonstrated that identifying and analysing the stakeholders involved in allocating foreign currency subsidies to medicines can provide valuable information for policy-makers to enable a more comprehensive understanding and better capacity to determine whether or not to eliminate these subsidies. Moreover, decision-making in this process is a long-term issue that requires consensus among all stakeholders. Because of the political and social consequences of eliminating foreign currency subsidies, the necessary political will is not institutionalized. We recommend a step-by-step approach in eliminating foreign currency subsidies if the requirements are met (i.e., those related to the consequences of such interventions). Therefore, revision of the current policy along with these requirements, in addition to financial transparency and enhanced efficiency, will facilitate progress towards achieving the Sustainable Development Goals by improving access to medicines.

show abstract

“…This will be done based on four priori categories, namely: content, context, process and actors. The Reporting Items for Stakeholder Analysis (ie, the RISA tool) 45 will be used to guide the mapping of key stakeholders and their responsibilities in regulating the use of health applications for patient self-management.…”

Section: Methodsmentioning

confidence: 99%

Regulatory standards and guidance for the use of health applications for self-management in Africa: scoping review protocol

et al. 2022

View full text Add to dashboard Cite

IntroductionDespite health applications becoming ubiquitous and with enormous potential to facilitate self-management, regulatory challenges such as poor application quality, breach of data privacy and limited interoperability have impeded their full adoption. While many countries now have digital health-related policies/strategies, there is also a need for regulatory standards and guidance that address key regulatory challenges associated with the use of health applications. Currently, it is unclear the status of countries in Africa regarding regulatory standards and guidance that address the use of health applications.This protocol describes the process of conducting a scoping review which aims to investigate the extent to which regulatory standards and guidance address the use of health applications for self-management within the WHO African Region countries.MethodsThe review will follow the methodological framework for conducting a scoping study by Arksey and O’Malley (2005), and the updated methodological guidance for conducting a Joanna Briggs Institute (JBI) scoping review. Given that regulatory standards and guidance are unlikely to be available in scientific databases, we will search Scopus, Google, OpenGrey, WHO Regional Office for Africa Library (AFROLIB), African Index Medicus (AIM), websites of WHO, ITU and Ministries of Health, repositories for digital health policies. We will also search the reference lists of included documents, and contact key stakeholders in the region. Results will be reported using descriptive qualitative content analysis based on the review objectives. The policy analysis framework by Walt and Gilson (1994) will be used to organise findings. A summary of the key findings will be presented using tables, charts and maps.Ethics and disseminationThe collection of primary data is not anticipated in this study and hence ethical approval will not be required. The review will be published in a peer-reviewed journal while key findings will be shared with relevant organisations and/or presented at conferences.

show abstract

Stakeholder analysis in health innovation planning processes: A systematic scoping review

Cited by 40 publications

References 67 publications

Primary Healthcare meta-evaluation in Brazil: Lessons learned from the external assessment of the program to improve primary healthcare access and quality.

Primary Healthcare meta-evaluation in Brazil: Lessons learned from the external assessment of the program to improve primary healthcare access and quality.

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis

Regulatory standards and guidance for the use of health applications for self-management in Africa: scoping review protocol

Contact Info

Product

Resources

About